Nanologica AB (publ) (OM: NICA)
Health Care · Biotechnology · SE
Skr0.28
-9.09% today · -73.7% 1Y
Nanologica AB (publ) (OM: NICA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.09M and employs 72 people.
Over the last twelve months the share price has lost 73.7%, trading between 0.29 and 2.25.
Tweenvest scores Nanologica AB (publ) across four factors: quality 33/100, value 47/100, growth 100/100. Its strongest factor is growth.
NICA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.09M
- Revenue (TTM)
- $13.36M
- P/E
- 3.19
- EPS
- 0.10
- Dividend yield
- —
- Beta (5Y)
- -0.04
- 52-week high
- Skr2.25
- 52-week low
- Skr0.29
- Avg volume (3M)
- —
- Shares outstanding
- 328.77M
- Employees
- 72
- Next earnings
- —
About Nanologica AB (publ)
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
- ISIN
- SE0005454873
- Founded
- 2004
- Listed since
- Oct 30, 2015
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Brainstorm Cell Therapeutics Inc.OTCPK: BCLI | $10.26M | $0.93 | -4.10% |
| Nextage Therapeutics LtdTASE: NXTG | $10.19M | ₪0.39 | +9.30% |
| Medicus Pharma Ltd.NasdaqCM: MDCX | $10.17M | $0.10 | -36.52% |
| MetaVia Inc.NasdaqCM: MTVA | $10.15M | $1.42 | -7.79% |
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $10.04M | $0.32 | -0.71% |
| Active Biotech AB (publ)OM: ACTI | $9.96M | Skr3.79 | -10.82% |
| Chemomab Therapeutics Ltd.NasdaqCM: CMMB | $9.93M | $1.37 | 0.00% |
| Adaptimmune Therapeutics plcOTCPK: ADAP.Y | $9.81M | $0.04 | +45.10% |
Figures last refreshed Oct 4, 2026.